Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 25th Congress of the European Association of Urology

Androgen Deprivation Therapy in Prostate Cancer

Barcelona, Spain / April 16-20, 2010

Barcelona - New data have reinforced the utility of a gonadotropin-releasing hormone (GnRH) receptor blocker for slowing progression of advanced prostate cancer. Following a previous phase III study in which this agent compared favourably...

MEDICAL FRONTIERS - 16th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine

Improving Diagnosis and Safety: An Inside View of Recent Advances and Safety Developments in High-resolution Vascular and Cardiac MRI

Toronto, Ontario / May 3-9, 2008

Figure 1. In recent years, magnetic resonance angiography (MRA) has become a reliable diagnostic tool used in a variety of indications, including imaging of cerebral, thoracic, abdominal, renal and peripheral arteries. Several different...

Transcatheter Cardiovascular Therapeutics 2007

Contrast Agents: Hemodynamics, Electrolytes and Acute Kidney Injury

Washington, DC / October 20-25, 2007

Washington, DC - High-contrast coronary computed tomographic angiography (CTA) is a breakthrough technology for evaluating cardiac patients noninvasively. The ever-expanding volume of CTA procedures ranges in the millions, corresponding...

56th Annual Scientific Sessions of the American College of Cardiology

Controlling LDL and Atherosclerosis: Corroborative Evidence

New Orleans, Louisiana / March 25-28, 2007

New Orleans - For the first time, aggressive LDL reductions have been shown to halt progression of atherosclerosis in asymptomatic patients with relatively low cardiovascular (CV) risk. This is an important finding because it confirms that...

23rd Annual Cardiovascular Conference at Lake Louise

Management Evolution in Vulnerable Plaque

Lake Louise, Alberta / March 11-15, 2007

Lake Louise - Atherosclerotic vascular disease remains the leading cause of morbidity and mortality among adults in developed countries. Over the past few decades, a number of medications have proven useful in preventing symptomatic...

Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy: Focus on Gadolinium-based Contrast Media

Philadelphia, Pennsylvania / November 18, 2006

EDITORIAL OVERVIEW: Dr. James A. Tumlin Director of Clinical Research Southeast Renal Associates Associate Professor of Medicine University of North Carolina at Charlotte Charlotte, North Carolina PANEL Dr. Stanley Goldfarb University of...

Transcatheter Cardiovascular Therapeutics 2006

Reviewing the Scientific and Clinical Landscape of Contrast-Induced Nephropathy

Washington, DC / October 22-27, 2006

INTRODUCTION Despite a multitude of advances in radiographic and angiographic techniques in recent years, contrast-induced nephropathy (CIN) continues to pose technologic challenges and clinical problems. Modern imaging modalities rely...

Canadian Cardiovascular Congress 2006

New Guidelines for Lipids: Clinical and Biological Evidence

Vancouver, British Columbia / October 21-25, 2006

Vancouver - New Canadian guidelines on dyslipidemia diagnosis and treatment were emphasized in many sessions here at the CCC. The intervention point for low-risk individuals in LDL-C levels is now 5 mmol/L or a total cholesterol:HDL-C ratio...

55th Annual Scientific Sessions of the American College of Cardiology

Confirming Change in the Natural History of Atherosclerosis with Intravascular Ultrasound

Atlanta, Georgia / March 11-14, 2006

Atlanta - Concepts about the natural history of cardiovascular disease have been profoundly altered. Using intravascular ultrasound (IVUS), a tool that can quantify the burden of disease, it has demonstrated that aggressive lipid lowering...

PAGE 1 OF 1   1